Christoph Minichsdorfer

Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial

Rupert Bartsch, Anna S. Berghoff, Julia Furtner et al. · Nature Medicine · 2022 · 374 citations · Full text

Genome-Wide miRNA Expression Profiling Identifies <i>miR</i> - <i>9</i> - <i>3</i> and <i>miR</i> - <i>193a</i> as Targets for DNA Methylation in Non–Small Cell Lung Cancers

Gerwin Heller, Marlene Weinzierl, Christian Noll et al. · Clinical Cancer Research · 2012 · 158 citations · Full text

Delineation of cell death mechanisms induced by synergistic effects of statins and erlotinib in non-small cell lung cancer cell (NSCLC) lines

Alexander Otahal, Duygu Aydemir, Erwin Tomasich et al. · Scientific Reports · 2020 · 51 citations · Full text

Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases

Rupert Bartsch, Anna S. Berghoff, Julia Furtner et al. · Neuro-Oncology · 2024 · 48 citations · Full text

PD-L1 Expression on Tumor Cells Is Associated With a Poor Outcome in a Cohort of Caucasian Nasopharyngeal Carcinoma Patients

Christoph Minichsdorfer, Felicitas Oberndorfer, Christoph Krall et al. · Frontiers in Oncology · 2019 · 35 citations · Full text